NSG552 / NSG 552 Exam 3 (Latest 2024 / 2025): Psychopharmacology | Complete Guide with Verified Answers | 100% Correct - Wilkes

Exam 3: NSG552 / NSG 552 (Latest 2024 / 2025) Psychopharmacology Exam Review | Complete Guide with Verified Answers | 100% Correct - Wilkes Q: Signs vary with blood levels, from decreased reaction time, muscle incoordination, ataxia, dysarthria, to respiratory failure and coma. Answer: alcohol intoxication Q: Levels of alcohol intoxication that require no formal treatment. Answer: mild to moderate Q: Treatment includes cardiopulmonary function maintenance, thiamine, and haloperidol PRN agitation. Answer: severe alcohol intoxication Q: Given IM/IV for 3 days to prevent Wernicke's encephalopathy, along with IV fluids and a banana bag. Answer: thiamine Q: Class of drugs to avoid for acute alcohol intoxication. Answer: benzodiazepines Q: Treatment includes BZD in either symptom triggered or fixed dose; diazepam and chlordiazepoxide have a longer half life, and oxazepam and lorazepam are suitable for pat Answer: uncomplicated alcohol withdrawal Q: BZDs with a long half-life used to treat AUD. Answer: diazepam and chlordiazepoxide Q: BZDs with moderate half-life used in AUD patients with liver disease. Answer: oxazepam and lorazepam Q: BZD for AUD that should be avoided in patients with severe liver disease. Answer: chlordaizepoxide Q: Treatment includes diazepam IV or lorazepam IV/IM, thiamine IV/IM, and addressing electrolyte imbalances. Answer: alcohol withdrawal seizures Q: For patients with mild symptoms and no history of seizures or delirium tremens, supervised withdrawal can be managed safely and effectively in the ambulatory setting. Answer: AUD Q: Treatment includes acute care management, parenteral diazepam or lorazepam, thiamine, and antipsychotics if necessary. Answer: DT Q: Usually auditory, antipsychotic agents are used to treat. Answer: alcohol hallucinosis Q: MOA is via negative reinforcement, where drinking is avoided due to unpleasant effects. Answer: disulfiram Q: NMDA receptor antagonist that is renally cleared, suitable for AUD patients with hepatic dysfunction. Answer: